EPA Revisits PFAS Reporting (Again)

November 11, 2025

Reading Time : 2 min

By: David H. Quigley, Shivani Swami (International Law Advisor)

On November 10, 2025, the U.S. Environmental Protection Agency (EPA) released the pre-publication draft proposed rule to amend the PFAS reporting requirements under TSCA, entitled “Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) Data Reporting and Recordkeeping Under the Toxic Substances Control Act (TSCA); Revision to Regulation.” The proposal aims to augment the exemptions to the scope of the reporting requirements and introduces additional modifications to make the rule “more practical and implementable and reduce unnecessary, or potentially duplicative, reporting requirements for businesses.” Potentially offering even greater flexibility, it concludes with a request for comment on additional provisions. 

As you already know, the original rule, finalized in October 2023, imposed a one-time requirement on entities that manufactured or imported PFAS or PFAS-containing products in any year between 2011 and 2022 to report data related to PFAS exposure and environmental and health effects to EPA. After two extensions due to delays in developing the reporting portal, the reporting window currently is set to open April 13, 2026, and close October 13, 2026. The proposed rule will delay it further, to begin 60 days after the final rule’s effective date and remain open for three months.

Under the proposed revisions, EPA would exempt PFAS manufactured or imported in mixtures or products at concentrations of 0.1% or lower, regardless of total production volume. Imported articles would also be excluded, as would PFAS manufactured as byproducts, impurities and non-isolated intermediates. PFAS manufactured or imported in small quantities for research and development purposes would likewise be exempt.

The proposal also contains technical corrections to the original rule, including changes to the scope and format of the health effects information required to be reported and changes to the names of certain consumer and commercial product categories. EPA proposes all of these changes to better align the information requested with the information needed under TSCA, and to ensure it comes from the parties most likely to have relevant information while minimizing duplication.

Lastly, the proposal outlines a number of specific requests for comment, including some regarding the provisions discussed above and others that may indicate a willingness to provide further dispensation through additional provisions. This latter category includes requests for comment on the scope of reportable chemicals (though not mentioned, this seems to open the door for a fluoropolymer discussion) and the EPA’s underlying economic analysis. 

Akin will continue to closely monitor the space and provide updates here – stay tuned!

Share This Insight

Previous Entries

PFAS Press

February 17, 2026

We have previously discussed here the somewhat groundbreaking approach (in the U.S. anyway) taken by New Mexico’s Per- and Polyfluoroalkyl Substances (PFAS) Protection Act, enacted in March 2025, which included a first of its kind exemption for fluoropolymers from the law’s sales bans on PFAS-containing products. Subsequent regulatory actions in the state proposed excluding certain federally-regulated (and fluoropolymer-containing) products, including U.S. Food and Drug Administration (FDA) regulated medical devices, from the scope of labeling requirements. The New Mexico Environmental Improvement Board (EIB) currently is accepting public input on those proposed labeling rules, with public testimony scheduled to begin February 23 and written comments due by March 31. After recent legislative moves, it appears that participation in this comment period may be of the utmost importance to the regulated community. On February 5, 2026, the House Energy, Environment and Natural Resources Committee recommended passage of House Joint Memorial 3, which alleges a “limited scientific literature” supporting the above moves to exempt fluoropolymers and requests that the New Mexico Environment Department prepare a report evaluating implementation of the PFAS Protection Act, including the effectiveness of EIB’s rules and assessing the health, environmental and economic implications of statutory and regulatory exemptions, and provide recommendations on whether exemptions such as the fluoropolymer carve out should be maintained, revised or eliminated. Manufacturers seeking to maintain the exemptions will want to use the comment period to support doing so.

...

Read More

PFAS Press

January 22, 2026

Akin environment & natural resources practice head David Quigley is quoted by Chemical Watch news & events by Enhesa in the third part of its 2026 Global Outlook series titled, “What’s next for state-level chemicals policy in the US in 2026?” discussing his expectations for state-level chemical policy trends in 2026 and the outlook for regulation and enforcement especially as it relates to PFAS.

...

Read More

PFAS Press

January 20, 2026

To ring in the new year, New Jersey became the latest state to enact legislation banning intentionally-added PFAS in certain consumer products. In the final days of his term, Governor Murphy signed into law the Protecting Against Forever Chemicals Act (S 1042), which prohibits the sale of cosmetics, carpets, fabric treatments and food packaging containing intentionally-added PFAS starting in January 2028. The law also requires manufacturers to label certain direct food contact consumer cookware that contains intentionally-added PFAS. Interestingly, the legislature stripped forward-looking provisions excluding fluoropolymers just prior to passage. Definitely an area to watch as additional states dip their feet in the PFAS pool in 2026.  

...

Read More

PFAS Press

December 15, 2025

On December 8, 2025, the Minnesota Pollution Control Agency (MPCA) finalized its PFAS-in-Products program rules in response to an Administrative Law Judge order requiring the Agency to reduce fees, among other changes. Under the rule, manufacturers must submit PFAS information – including product descriptions, PFAS type, quantity, function and manufacturer details – to MPCA by July 2026, and pay a fee to support the program.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.